6
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Daledalin Tosylate: A Controlled Trial in Depressive Illness

, M.B., Ch.B., M.R.C.Psych., D.P.M. & , MB., B.S., M.R.C.Psych., D.P.M.
Pages 305-312 | Received 22 Apr 1974, Published online: 04 Aug 2008

Reference

  • Basic Data UK 3557. (1968). Therapeutics Research Division, Pfizer Limited, Sandwich, England.1. Basic Data UK 3557. (1968). Therapeutics Research Division, Pfizer Limited, Sandwich, England.
  • Canas-Rodrigues, A., and Leeming, P. R., (1969). N-phenyl indoline derivatives - a new class of antidepressant agents. Nature, 233, 75–76.2. Canas-Rodrigues, A., and Leeming, P. R., (1969). N-phenyl indoline derivatives - a new class of antidepressant agents. Nature, 233, 75–76.
  • Eysenck, H. J., (1952). “The Scientific Study of Personality”. Routledge and Kegan Paul, London.3. Eysenck, H. J., (1952). “The Scientific Study of Personality”. Routledge and Kegan Paul, London.
  • Eysenck, H. J., (1970). The classification of depressive illness. Brit. J. Psychiat., 117, 241–250.4. Eysenck, H. J., (1970). The classification of depressive illness. Brit. J. Psychiat., 117, 241–250.
  • Hamilton, M., (1960). A rating scale for depression. J. Neurol. Neurosurg. Psychiat., 23, 56–61.5. Hamilton, M., (1960). A rating scale for depression. J. Neurol. Neurosurg. Psychiat., 23, 56–61.
  • Kendall, R. E., (1968). “The Classification of Depressive Illness.“ University Press, Oxford.6. Kendall, R. E., (1968). “The Classification of Depressive Illness.“ University Press, Oxford.
  • Snaith, R. P., Ahmed, S. N., Mehta, S., and Hamilton, M., (1971). Assessment of the severity of primary depressive illness. Psycholog. Med., 1, 143–149.7. Snaith, R. P., Ahmed, S. N., Mehta, S., and Hamilton, M., (1971). Assessment of the severity of primary depressive illness. Psycholog. Med., 1, 143–149.
  • Wheatley, D., (1973). Clinical evaluation of a new chemical compound with antidepressant properties. Brit. J. Psychiat., 121, 621–622.8. Wheatley, D., (1973). Clinical evaluation of a new chemical compound with antidepressant properties. Brit. J. Psychiat., 121, 621–622.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.